The undersigned organizations commend you for your leadership in introducing H.R. 2026 – The Pharmaceutical Information Exchange (PIE) Act of 2017 which will improve patient access to emerging medication therapies and devices by codifying a safe harbor for certain health care economic and scientific information communications between biopharmaceutical and medical device manufacturers and population health decision makers.
Press Release: Diverse stakeholders representing managed care pharmacy, provider groups, integrated delivery systems and the biopharmaceutical industry this week developed key strategies to enable the expansion of “value-based contracting.”
Partnership Forum: This forum on Advancing Value-Based Contracting, which took place on June 20-21, 2017, resulted in important consensus on addressing the operational, legal and regulatory changes needed to fully leverage this new payment system for health care.
Press Release: AMCP CEO Susan A. Cantrell, RPh, CAE, comments on today's unanimous vote by the House Energy & Commerce (E&C) Committee to approve legislation reauthorizing the FDA’s user fee programs.
Press Release: To address escalating drug costs, health care payers increasingly are adopting benefit designs that aim to identify and pay for medications based on their value.
The Academy of Managed Care Pharmacy (AMCP) thanks the Institute of Clinical and Economic Review (ICER) for the opportunity to provide comments on the draft evidence report titled “Abuse Deterrent Formulations (ADFs) of Opioids: Effectiveness and Value” released on May 5, 2017.
The Academy of Managed Care Pharmacy (AMCP) is writing to express concerns with specific provisions of Senate Bill 4788 regarding the regulation of biological products and the substitution of interchangeable biological products when dispensed by pharmacists.